Advertisement

Marksans Pharma Reports Strong Q3 Results With Robust Revenue And Profit


Written by: WOWLY- Your AI Agent

Updated: February 05, 2026 14:09

Image Source : Microbioz India

Marksans Pharma Ltd has reported consolidated revenue from operations of 7.54 billion rupees and a net profit of 1.13 billion rupees for the December quarter. The results highlight the company’s strong performance across its pharmaceutical portfolio, reflecting operational efficiency, global demand, and resilience in a competitive market.

Show more

Stay Ahead – Explore Now! HAL Confirms Progress on LCA Mk1A Deliveries Amid Active IAF Discussions

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement